Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
08/28/18
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018
08/16/18
Arch Therapeutics Announces Poster Presentation at the 2018 Military Health System Research Symposium on Tuesday, August 21, 2018
07/20/18
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
06/29/18
Arch Therapeutics, Inc. $4.5 Million Registered Direct Offering
06/26/18
Arch Therapeutics Provides Skin Sensitization Study Status Update
06/15/18
Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study
05/15/18
Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 2018
05/8/18
Arch Therapeutics Provides Update on Study Initiation and 510(k)
03/12/18
Arch Therapeutics Provides Update on 510(k)
03/5/18
Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018
<< Previous
1...
5
6
7
8
9
10
11
12
13
14
Next >>
Show All